Full tender Source status Β· 2 documents Β· Completeness: 45%
- AVVISO.pdf (avviso, 1 pp.)
- estratto_173858031.pdf (estratto, 2 pp.)
π΄ NO-GO
Focus: coagulazione POCT Β· Deadline: historical/outcome Β· Exclusivity risk: low
Non-binding expression of interest with a 15/09/2023 deadline largely expired; although fully in focus (POCT coagulation) it is no longer submittable.
π― Merit only (ignore deadline): TO EVALUATE β POCT coagulation expression of interest (PT/APTT/ACT) with generic requirements: in principle contestable, depended on the catalogued system.
TENDER ANALYSIS No. 13993558
Document generated on 04/06/26 15:24
TENDER IDENTIFICATION DATA
| TENDER SUBJECT | Market consultation for an expression of interest pursuant to art. 50 paragraph 2 - Annex II.1 Legislative Decree no. 36 of 31 March 2023, for the acquisition of 3 coagulation tests required by the Cardiothoracic Anesthesia and Intensive Care unitSource: AVVISO.pdf: pagina 1 |
| CONTRACTING AUTHORITY | Fondazione IRCCS Policlinico San Matteo - Purchasing Management Unit (Procurement-Economato), V.le Golgi 19, 27100 PaviaSource: AVVISO.pdf: pagina 1 |
| CIG (tender ID) | Not stated |
| PROCEDURE TYPE | Market survey / Expression of interest pursuant to art. 50 paragraph 2 - Annex II.1 Legislative Decree 36/2023 (Negotiation - medical devices)Source: AVVISO.pdf: pagina 1; estratto_173858031.pdf: pagina 1 |
| PLATFORM | SINTEL (ARIA)Source: AVVISO.pdf: pagina 1; estratto_173858031.pdf: pagina 2 |
| PLACE OF PERFORMANCE | Fondazione IRCCS Policlinico San Matteo, Pavia (Cardiothoracic Anesthesia and Intensive Care)Source: AVVISO.pdf: pagina 1 |
| AWARD CRITERION | Not stated (expression of interest, no economic offer; proposals/offers of an economic nature are not admitted)Source: AVVISO.pdf: pagina 1 |
| BID SUBMISSION DEADLINE | 15/09/2023 at 16:00 CESTSource: AVVISO.pdf: pagina 1; estratto_173858031.pdf: pagina 1 |
| TOTAL AMOUNT | Not stated (auction base not quantified; the portal requires a symbolic value of β¬ 1.00 not considered, safety costs β¬ 0.00)Source: AVVISO.pdf: pagina 1; estratto_173858031.pdf: pagina 1 |
| PNRR (recovery funds) | Not stated |
PARTICIPATION REQUIREMENTS
| ELIGIBILITY REQUIREMENTS | Not stated |
| ECONOMIC CAPACITY | Not stated |
| TECHNICAL CAPACITY | Not stated (submission of technical data sheets of the devices is requested)Source: AVVISO.pdf: pagina 1 |
| SOA CATEGORY | Not stated |
| CREDIT LICENCE | Not stated |
| ADDITIONAL REQUIREMENTS | Not stated |
| WHITE LIST | Not stated |
PRELIMINARY OBLIGATIONS
| BID BOND | Not stated |
| ANAC FEE | Not stated |
| SITE INSPECTION | Not stated |
| SAMPLING | Not stated (only technical data sheets requested)Source: AVVISO.pdf: pagina 1 |
| TIMESTAMP / DIGITAL SIGNATURE | Not stated |
| TECHNICAL OFFER | A declaration of interest on letterhead + technical data sheets are required, to be uploaded into the SINGLE ENVELOPE. Proposals/offers of an economic nature are prohibitedSource: AVVISO.pdf: pagina 1; estratto_173858031.pdf: pagina 2 |
| STAMP DUTY | Not stated |
| LABOUR CONTRACT (CCNL) | Indication of the CCNL (national collective labour agreement) applied to the employees engaged in the contract is requiredSource: AVVISO.pdf: pagina 1 |
| ACCELERATION BONUS | Not stated |
| SUBCONTRACTING | Not stated |
| RELIANCE (avvalimento) | Not stated |
| RTI / CONSORTIUM | Not stated |
| CLARIFICATIONS DEADLINE | Not stated (contacts for clarifications: Dr. Antonina Sottile tel. 0382-502379, a.sottile@smatteo.pv.it)Source: AVVISO.pdf: pagina 1 |
| FVOE (virtual file) | Not stated |
Custom questions
Is this a demanding procedure for the contracting authority?
No: the notice does not presuppose the formation of a ranking and is not binding for the Foundation, which reserves the right to interrupt, modify or terminate the consultation; it will be revoked if the devices in question are present in active ARIA framework agreements Source: AVVISO.pdf: pagina 1
Is the CPV declared?
Yes, main CPV 33190000-8 - Miscellaneous medical devices and products Source: estratto_173858031.pdf: pagina 1
What is the duration of the supply?
12 months (acquisition method: Purchase, 12 months) Source: estratto_173858031.pdf: pagina 1
Is an evaluation Commission envisaged?
No, the evaluation Commission is not activated Source: estratto_173858031.pdf: pagina 2
TECHNICAL ANALYSIS
Subject: Market consultation for an expression of interest for the acquisition of 3 coagulation tests required by the Cardiothoracic Anesthesia and Intensive Care unitTotal base amount: Not statedNo. of lots: 1
LOT 1 β POCT coagulation tests for Cardiothoracic Anesthesia and Intensive Care
| CIG | Not stated |
| Description / what it is | Market survey to identify operators interested in supplying a portable point-of-care coagulation testing system/instrument for use in the operating room/cardiothoracic intensive care (monitoring of oral anticoagulant therapy, heparin therapy and heparin management during surgical procedures). No economic offer at this stage: only a declaration of interest and technical data sheets are submitted. What it is in practice: a portable point-of-care (POCT) coagulometer at the patient's bedside. |
| System / instrumentation | Battery-powered portable instrument for POCT (point-of-care) coagulation |
| Base amount | Not stated (auction base not quantified; economic value not admitted at the expression-of-interest stage) |
| Volumes | Not stated (object: 3 coagulation tests) |
| Duration | 12 months |
| Required tests | - PT - to monitor oral anticoagulant therapy and as a screening test
- APTT - to monitor heparin therapy at therapeutic levels and as a screening test
- ACT - to monitor moderate and/or high heparin levels during surgical procedures
- ACT-LR - to monitor low and/or moderate heparin levels during surgical procedures
- Tests available on citrated blood: PT and APTT
|
| Technical requirements | - Battery-powered portable instrument
- PT performance (oral anticoagulant therapy + screening)
- APTT performance (heparin therapy + screening)
- ACT performance (moderate/high heparin in surgery)
- ACT-LR performance (low/moderate heparin in surgery)
- Availability of PT and APTT tests on citrated blood
|
| Sampling | Not stated (only technical data sheets requested) |
| Notes | SHOWSTOPPER: this is not an awardable tender but a simple market survey/expression of interest, non-binding for the Foundation and revocable if the devices fall within active ARIA framework agreements; the 15/09/2023 deadline is largely past (over 2.5 years ago) -> historical opportunity, no longer submittable. FIRSTECK COMPETITIVENESS: technical profile fully in focus (POCT coagulation on a battery-powered portable instrument, PT/APTT/ACT/ACT-LR on citrated blood), typical field of portable analyzers for cardiac surgery/ECC. To be used as a reference to map future similar surveys by San Matteo. |
| Sources | - AVVISO.pdf: pagina 1
- estratto_173858031.pdf: pagina 1
- estratto_173858031.pdf: pagina 2
|
Assessment for Firsteck Bio
The product falls fully within the Firsteck focus (POCT coagulation): a battery-powered portable instrument for PT, APTT, ACT and ACT-LR, also on citrated blood, for monitoring in the cardiothoracic operating room/intensive care. Technically the opportunity would be of interest, but this is a simple non-binding expression of interest with a 15/09/2023 deadline now largely past: it is no longer possible to participate. Its value lies as market intelligence to intercept the future actual tender of Policlinico San Matteo for this requirement.